Volume 13, Number 10—October 2007
Research
Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza1
Table 2
Participating institutions and time patient spent in each area*
Characteristic | Hospital |
||||||||
---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | G | H | I | |
State | VIC | VIC | VIC | VIC | VIC | TAS | VIC | VIC | NSW |
Urban/regional | Urban | Urban | Urban | Urban | Regional | Urban | Urban | Urban | Urban |
Inpatient beds, no. | 840 | 320 | 750 | 450 | 400 | 490 | 400 | 400 | 880 |
Annual admissions | 67,700 | 40,000 | 79,500 | 47,200 | 61,200 | 52,300 | 45,300 | 93,100 | 71,600 |
Total simulation time, h | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 2.5 | 2.5 |
Triage time, h | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 |
ED time, h† | 2 | 2.9 | 3 | 1.9 | 2.2 | 1.5 | 2.4 | 2.3‡ | 2.4‡ |
Ward time, h | 3.7 | 2.8 | 3 | 3.9 | 3.7 | 4.4 | 3.5 | – | – |
*VIC, Victoria; TAS, Tasmania; NSW, New South Wales; ED, emergency department.
†Includes time spent in ED radiology unit.
‡Simulation of avian or pandemic influenza ended prematurely because beds were needed.
1This research was presented in part at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, September 17-20, 2007.